Accounts expire at the end of Winter term
Ross databases focused on the pharmaceutical, medical device and power industries that also offer industry-wide analysis and specific deal information are a great resource for additional deal details.
EvaluatePharma is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors. Information includes sales by indication, licensing deals, merger & acquisitions, venture financing, IPOs, and orphaned drugs.
For more information see the EvaluatePharma Overview page.
Technical Notes:Accounts must be requested from EvaluatePharma. Details available after iMpact login.